Dr. Lal Pathlabs Q4 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
2,823.75
-52.55 (-1.83%)
-52.55 (-1.83%)Volume1.01 K
Updated: Fri 24 Jan, 2025 | 15:28:16
NSE
2,828.85-48.80 (-1.70%)
-48.80 (-1.70%)Volume2.96 L
Updated: Fri 24 Jan, 2025 | 15:31:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr. Lal Pathlabs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 23 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 545.44 | 538.90 | 1.21% | 490.98 | 11.09% |
| Selling/ General/ Admin Expenses Total | 181.08 | 186.70 | -3.01% | 161.36 | 12.22% |
| Depreciation/ Amortization | 36.60 | 36.00 | 1.66% | 37.59 | -2.65% |
| Other Operating Expenses Total | 110.80 | 104.60 | 5.93% | 108.24 | 2.37% |
| Total Operating Expense | 437.40 | 434.30 | 0.71% | 413.04 | 5.90% |
| Operating Income | 108.05 | 104.60 | 3.29% | 77.94 | 38.62% |
| Net Income Before Taxes | 119.85 | 115.90 | 3.41% | 83.13 | 44.18% |
| Net Income | 84.53 | 81.30 | 3.98% | 56.65 | 49.23% |
| Diluted Normalized EPS | 10.17 | 9.76 | 4.16% | 6.82 | 49.15% |